Neil Chatterji
Stock Analyst at B. Riley Securities
(1.71)
# 3,438
Out of 5,131 analysts
19
Total ratings
35.29%
Success rate
3.69%
Average return
Main Sectors:
Stocks Rated by Neil Chatterji
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintains: Buy | $20 → $28 | $14.92 | +87.67% | 4 | Apr 25, 2025 | |
| OPRX OptimizeRx | Maintains: Buy | $17 → $13 | $13.16 | -1.22% | 3 | Dec 24, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $95 → $50 | $68.34 | -26.84% | 2 | Nov 9, 2023 | |
| ARAY Accuray | Reiterates: Buy | $7.5 | $0.88 | +748.22% | 1 | Oct 4, 2023 | |
| ZUMZ Zumiez | Maintains: Neutral | $15 → $18 | $25.88 | -30.45% | 2 | Sep 8, 2023 | |
| KRMD KORU Medical Systems | Initiates: Buy | $4.5 | $5.65 | -20.35% | 1 | Sep 7, 2023 | |
| HYPR Hyperfine | Maintains: Buy | $2.5 → $3.5 | $1.01 | +246.53% | 3 | Aug 15, 2023 | |
| STXS Stereotaxis | Maintains: Buy | $6 → $5.5 | $2.51 | +119.12% | 2 | Mar 6, 2023 | |
| BFLY Butterfly Network | Initiates: Buy | $9.5 | $4.04 | +135.15% | 1 | Oct 4, 2022 |
ClearPoint Neuro
Apr 25, 2025
Maintains: Buy
Price Target: $20 → $28
Current: $14.92
Upside: +87.67%
OptimizeRx
Dec 24, 2024
Maintains: Buy
Price Target: $17 → $13
Current: $13.16
Upside: -1.22%
Establishment Labs Holdings
Nov 9, 2023
Maintains: Buy
Price Target: $95 → $50
Current: $68.34
Upside: -26.84%
Accuray
Oct 4, 2023
Reiterates: Buy
Price Target: $7.5
Current: $0.88
Upside: +748.22%
Zumiez
Sep 8, 2023
Maintains: Neutral
Price Target: $15 → $18
Current: $25.88
Upside: -30.45%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4.5
Current: $5.65
Upside: -20.35%
Hyperfine
Aug 15, 2023
Maintains: Buy
Price Target: $2.5 → $3.5
Current: $1.01
Upside: +246.53%
Stereotaxis
Mar 6, 2023
Maintains: Buy
Price Target: $6 → $5.5
Current: $2.51
Upside: +119.12%
Butterfly Network
Oct 4, 2022
Initiates: Buy
Price Target: $9.5
Current: $4.04
Upside: +135.15%